News - Page 196 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Nova Mentis Establishes Serotonin Research Centre

Nova Mentis Establishes Serotonin Research Centre

Post published:March 31, 2021
Post category:Press Release

Read more about the article Psyence Group and Pure Extracts Sign JV Letter of Intent for the Extraction of Psilocybin from Psychedelic Mushrooms and Development of Psilocybin Formulations

Psyence Group and Pure Extracts Sign JV Letter of Intent for the Extraction of Psilocybin from Psychedelic Mushrooms and Development of Psilocybin Formulations

Post published:March 31, 2021
Post category:Press Release

Read more about the article MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS

MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS

Post published:March 30, 2021
Post category:Press Release

Read more about the article Noetic Launches Venture Studio to Build Psychedelic Biotechnology Companies

Noetic Launches Venture Studio to Build Psychedelic Biotechnology Companies

Post published:March 30, 2021
Post category:Press Release

Read more about the article Cybin Announces Senior Management Changes to Lead Buildout of Development and Clinical Capabilities in the United States and Europe

Cybin Announces Senior Management Changes to Lead Buildout of Development and Clinical Capabilities in the United States and Europe

Post published:March 30, 2021
Post category:Press Release

Silo Wellness Hires Two Veterans of Lifestyle Marketing and Cannabis Industry to Promote Marley Line of Functional & Psychedelic Mushroom Brand

Post published:March 30, 2021
Post category:Press Release

Read more about the article Psyched Wellness Initiates Study on AME-1 Extract for Gut Health

Psyched Wellness Initiates Study on AME-1 Extract for Gut Health

Post published:March 30, 2021
Post category:Press Release

Read more about the article MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform

MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform

Post published:March 30, 2021
Post category:Press Release

Read more about the article AIkido Pharma Sponsors Psychedelic Compound Research to Treat PTSD

AIkido Pharma Sponsors Psychedelic Compound Research to Treat PTSD

Post published:March 29, 2021
Post category:Press Release

Read more about the article Nova Mentis Announces Promising Research Results

Nova Mentis Announces Promising Research Results

Post published:March 29, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.